Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

"Let's adopt a lifecycle management approach to method development to ensure continued excellence."

Cell therapy manufacturing? It's time to scale out.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.

The complexity and scope of tasks within (bio)pharma lends itself to outsourcing, but finding the right partner can be daunting.

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

Georg Winter has cinched Eppendorf's 2019 Young European Scientist award.

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.